Welcome      Properties & Application      Gastroenterology



 

InhibirelA® is a beneficial food supplement in dietary and therapeuticregimen for several disorders of digestivetract, such as:

·         Liver disorders

·         Digestive Disorders

·         Gallstones

·         Ulcer dyspepsia

·         Acute pancreatitis

·         Crohn disease

·         Ulcerative Colitis

·         Irritable Bowel Syndrome

·         Familial adenomatous polyposis

InhibirelА®
Food Supplement 
60 gelatin capsules for oral intake. 
95% Curcumin Extract, 200 mg
The product is a food supplement, not a medicament and does not replace the full (balanced) diet, the need for physical activity and necessity of appropriate medication.
Contains no heavy metals, GMOs and irradiated ingredients.
Do not exceed the recommended daily dose.
Should not be used by pregnant or nursing women.
The product is not intended for persons under 18 years.
Contraindications: None known

 

InhibirelA®

by gastroenterological indications

 
 
Anti-inflammatory and anti-toxic action:
 

·         Improves digestion.

·         Strengthens and protects esophageal (food tract). Supports the urinary and excretory system.

·         Relieves state ulcers and gastritis.

·         Inhibits inflammatory processes, and especially the food tract and colon.

·         Acts hepatoprotective, strengthens the livergallbladder and pancreas.

·         Reduces the harmful effects of hepatotoxic drugs (eg paracetamol) and manifestations of excessive use of alcohol, tobacco and overeating.

 
 

Intake of InhibirelA®  during gastroenterological indications:


Anti-inflammatory action:
Particularly noteworthy is the effect ofInhibirelA® on inflammatory bowel diseases such as Crohn's disease (Crohn or ulcerative proctitis - a form of ulcerative colitis affects only the colon)) and ulcerative colitis, significantly reduces the probabilityrecurrence of the disease, relieves symptoms (decreased frequency of stools, normal stool consistency and reduces pain and spasms) and contributes to the normalization of laboratory parameters as velocity of erythrocyte sedimentation rate (ESR) and levels of C-reactive protein (CRP).
Reduces intestinal polyps:
InhibirelA® has a beneficial effect in patients with familial adenomatous polyposis (FAP) - a hereditary disease in which polyps (adenomas) are occurring in the colon, part of which can develop into cancer (colon cancer) - as can greatly reduce the polyps.
Anti-biotic action:
InhibirelA® has also an expressed antibacterial, antimicrobial, antiviral and antifungal activity, which is especially pronounced in infections of the gastrointestinal tract and urinary tract.
Thanks to this effective action 
InhibirelA®can be successfully countered by infectious agents: H. pillory, Candida, Schistosoma mansoni, Malaria, E. coli, Staphylococcus aureus, Bacillus cereus, Salmonella typhimurium.
In this regard, InhibirelA® may also potentiate and enhance the antibacterial effect of some antibiotics such as: cefixime, cefotaxime, vancomycin and tetracycline.

Ulcers, dyspepsia, gastritis, pancreatitis:
InhibirelA® relieves the symptoms of ulcer, dyspepsia, peptic ulcer and pancreatitis.Protects the gastric mucous layer, reduces the acidity of the stomach contents, regulates the secretion of gastric juices, thereby protecting the gastrointestinal tract from the formation of ulcers. Regulates the function of the pancreas.
Irritable bowel syndrome:
InhibirelA® relieves symptoms in irritable bowel syndrome - representing intestinal motility disorder characterized by chronic recurrent gastrointestinal symptoms (changes in bowel habits, abdominal pain, etc..) In the absence of organic causes.
Biliary insufficiency:
InhibirelA® stimulates bile production and accelerates the emptying of the gallbladder, thereby counteracting the formation of gallstones (cholelithiasis), whose presence is a risk factor for gallbladder cancer.
Hepatoprotective effects:
InhibirelA® has hepatoprotective effects, supporting digestive function of the liver and preventing disability, as a result of excessive alcohol consumption, a diet high in unsaturated fats and other toxic substances, incl. hepatotoxic drugs.

 

·         to improve digestion,

·         by different chronic inflammatory processes of digestive tract,

·         hepatoprotective and anti-toxic intake: 

2-3 capsules of 200 mg daily  - 1 capsule before meal 2-3 times a day for a period of 1 to 6 months or when necessary.
 
Tips for intake: the capsule contents dissolved in a glass of fruit juice or warm water withlemon.
Do not overdose the recommended daily intake. Do not use during pregnancy or lactation. This product is not intended for persons under 18 years old.


 

INHIBIRELA
is a food supplement designed for active people striving for healthy and satisfying 
Lifestyle.

 
 

www.inhibirela.com © Copyright 2017 LifeConcept Ltd.  All rights reserved!

USE OF INFORMATION:
The information published on this site isintended solely for the use and application of InhibirelA® and may not be used for other purposes, including those for diagnosis and treatment of diseases.